About IGENOMIX

Igenomix is a medical testing laboratory specializing in reproductive genetic services.
We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services for IVF clinics, founded in 2011. Together we create Vitolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey.

Based on science and advanced research capabilities, our aim is to deliver products and services for the entire fertility journey, providing consistent performance and guaranteed quality. We are a sustainable market leader and aim to be the preferred partner to the fertility clinics by providing superior products and services. Currently, Vitrolife Group are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 110 countries, through our own presence in 30 countries, and a network of distributors.

Our vision is to fulfil the dream of having a healthy baby, and we achieve this by supporting our customers in delivering successful treatment outcomes. We are your committed partner for the IVF journey. We can help you maximise success. – Together. All the way.

The Vitrolife AB (publ) share is listed on Nasdaq Stockholm.

website icon
Website
employees icon
Employees
501-1,000 employees View all IGENOMIX employees link out icon
industry icon
Industry
Biotechnology
location icon
Headquarter
Ronda Narciso Monturiol, nº11 B, Parque Tecnológico de Paterna, Paterna, VALENCIA 46980, ES
description icon
Keywords
Preimplantation Genetic Screening (Pgs), Preimplantation Genetic Diagnosis (Pgd), Carrier Genetic Test (Cgt), Endometrial Receptivity Array (Era), Non-Invasive Prenatal Test (Nace), Products Of Conception (Poc), Sperm Aneuploidy Test (Sat)

IGENOMIX Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about IGENOMIX

Who is the CEO of IGENOMIX?

Emily Yang is the CEO of IGENOMIX. To contact Emily Yang email at [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more